// App-Quantinova.ai

R6 : OLIGOCLONAL LYMPHOCYTOSIS ASSOCIATED WITH ELEVATED IL6 AND IL10 IN A CASE OF SEVERE CUTANEOUS ADVERSE DRUG REACTION

Researchers

Presenter

  • Yogesh Jeelall

Principal Investigators

  • Manu Singh

  • Jeffrey Lai

  • Syed Ali

  • Katherine Jackson

  • Peter N. Hollingsworth

  • Bastiaan de Boer

  • Benjamin Wood

  • J oanne Reed

  • Christopher Goodnow

  • Andrew Mclean-Tooke

  • Michaela Lucas

Medical Centers

  • School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia

  • Immunogenomics laboratory, Division of Immunology, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia

  • Department of Immunology, Sir Charles Gairdner Hospital, QEII Medical Centre, Nedlands, Western Australia

  • Department of Immunology, Sir Charles Gairdner Hospital, QEII Medical Centre, Nedlands, Western Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Immunoglobulin E

  • Immunoglobulin G

  • Interleukin 10

  • Interleukin 6

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Interleukin-10

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved